title: Antilactoferrin antibodies in autoimmune liver disease.
abstract: Antilactoferrin antibodies have been reported in patients with several autoimmune disorders, including primary biliary cirrhosis, autoimmune hepatitis and autoimmune cholangitis. We investigated the prevalence and the clinical significance of such autoreactivity in patients with autoimmune and viral chronic liver disease. Sera from 39 patients with autoimmune hepatitis, 51 with primary biliary cirrhosis, 17 with autoimmune cholangitis, 24 with primary sclerosing cholangitis and 28 with HCV-related chronic hepatitis were studied. Positivity for antilactoferrin antibodies was evaluated by Western immunoblotting with purified human lactoferrin. Antilactoferrin antibodies were detected more often in autoimmune liver disorders (25% autoimmune hepatitis, 25% primary biliary cirrhosis, 35% autoimmune cholangitis, 29% primary sclerosing cholangitis) than in HCV-related chronic hepatitis (3.5%, P < 0.02 versus all). Positivity for antilactoferrin antibodies was not associated with a particular clinical or biochemical profile of the underlying liver disease. No correlation was observed between antilactoferrin reactivity and perinuclear antineutrophil cytoplasmic antibodies. Antilactoferrin antibodies are present significantly more often in autoimmune than in viral liver disorders, but they cannot be considered the serological marker of a specific autoimmune liver disease.
authors.affiliation: Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy. muratori@med.unibo.it
authors.forename: L
authors.initials: L
authors.lastname: Muratori
authors.forename: P
authors.initials: P
authors.lastname: Muratori
authors.forename: D
authors.initials: D
authors.lastname: Zauli
authors.forename: A
authors.initials: A
authors.lastname: Grassi
authors.forename: G
authors.initials: G
authors.lastname: Pappas
authors.forename: L
authors.initials: L
authors.lastname: Rodrigo
authors.forename: F
authors.initials: F
authors.lastname: Cassani
authors.forename: M
authors.initials: M
authors.lastname: Lenzi
authors.forename: F B
authors.initials: FB
authors.lastname: Bianchi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D002761:Cholangitis / Q000097:blood / Q000276:immunology*; D015209:Cholangitis, Sclerosing / Q000097:blood / Q000276:immunology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood / Q000276:immunology*; D019693:Hepatitis, Autoimmune / Q000097:blood / Q000276:immunology*; D006801:Humans; D007781:Lactoferrin / Q000276:immunology*; D008105:Liver Cirrhosis, Biliary / Q000097:blood / Q000276:immunology*; D008297:Male; D008875:Middle Aged
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D001324:Autoantigens; D007781:Lactoferrin